Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
BlackRock, Inc. reported a 5.60% stake in Oric Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.60% stake in Oric Pharmaceuticals, Inc., 5,473,145 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 5,473,145
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.60% | 5,473,145 |
Source
Related
- Oric Pharmaceuticals, Inc.
- BlackRock, Inc.
- Oric Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Sep 25, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026
- Form 4 · Heyman Richard A. · Jul 28, 2026